Therefore, the PD1/PDL1 pathway is now recognized as one of the most important checkpoints for immune responses, and PD1/PDL1-blckades alone or in combination with other therapies have become the first line treatment standard in many different cancers such as TNBC and metastatic melanoma (11). The gene discussed is CD274; the disease is metastatic melanoma.